Drug Development Cost Estimate
This is a practical guide to building a cost estimate for a drug development project — a forecast of the money required to complete the work, adapted to the realities of developing a pharmaceutical product through regulatory stages.
What a Cost Estimate is
A cost estimate is a forecast of the money required to complete the work. For the full concept and how it works in general, see Cost Estimation. On a drug development project it plays the same role, tuned to this kind of work.
Why it matters for a Drug Development project
Drug Development projects live or die on developing a pharmaceutical product through regulatory stages. A well-built cost estimate gives the team a shared, explicit reference for exactly that — reducing ambiguity, aligning stakeholders, and making problems visible early enough to act. Skipping it, or doing it generically, is how drug development projects drift into avoidable delay and cost.
What to include
- Labour costs
- Material/equipment costs
- Indirect costs
- Contingency
- Estimate basis and assumptions
Drug Development-specific considerations
Tailor the cost estimate to the risks that most often derail drug development projects:
- Regulatory approval delays
- Trial/validation failures
- Strict GxP compliance
Example
On a real drug development project, the cost estimate would be shaped by developing a pharmaceutical product through regulatory stages. In particular, it should explicitly account for the project’s biggest risks — regulatory approval delays, trial/validation failures, strict GxP compliance — rather than treating them as afterthoughts.